Frec Markets Inc’s AstraZeneca AZN Stock Holding History

Frec Markets Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	6,171 +910	+17%	+$171K	0.11%	195
2026 Q1	$1.04M	Buy	5,261 +1,206	+30%	+$233K	0.18%	99
2025 Q4	$746K	Buy	+4,055	New	+$711K	0.22%	83

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Frec Markets Inc's AZN Position: Q2 2026 in Review

Frec Markets Inc increased its AstraZeneca (AZN) stake by 17% in Q2 2026, buying an estimated $171K and bringing the position to 6,171 shares worth $1.17M. The position accounts for 0.11% of the portfolio, ranked #195.

Frec Markets Inc first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Frec Markets Inc held 6,171 shares of AstraZeneca worth $1.17M as of Q2 2026.
Frec Markets Inc bought 910 AstraZeneca shares in Q2 2026, an estimated $171K.
AstraZeneca made up 0.11% of Frec Markets Inc's portfolio in Q2 2026, its #195 holding.
Frec Markets Inc first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.